ClinicalTrials.Veeva

Menu

Elaboration and Analysis of a New Cardiac Risk Stratification Protocol Based on Clinical and Physical Variables

U

Universidade Estadual Paulista Júlio de Mesquita Filho

Status

Completed

Conditions

Cardiovascular Diseases
Cardiovascular Risk Factor

Treatments

Other: Exercise-based cardiac rehabilitation program (Stage 2)
Other: Exercise-based cardiac rehabilitation program (Stage 1)

Study type

Observational

Funder types

Other

Identifiers

NCT04790643
35831220.8.0000.5402

Details and patient eligibility

About

This research project has as objective the elaboration and analysis of a new cardiac risk stratification protocol based on clinical and physical variables to predict the occurrence of signs and symptoms during a cardiac rehabilitation program. To this aim, the study will be developed in three stages. The first stage consists of a prospective longitudinal observational study, in which participants of exercise-based cardiac rehabilitation will undergo a physiotherapy evaluation in terms of physical and clinical aspects. After this initial assessment, participants will be followed for 2 months of rehabilitation, when the occurrence of signs and symptoms (chest pain, fatigue, dizziness, arrhythmias, and other minor events) during exercise will be recorded. Based on the data from the initial assessment and the occurrence of signs and symptoms a new cardiac risk stratification protocol will be developed. The second stage of this project consists of another prospective longitudinal observational study in which a new sample of individuals attending cardiac rehabilitation programs will be assessed and stratified for the risk of the occurrence of signs and symptoms during exercise by the new protocol developed. After the risk stratification, this sample will be followed for 2 months and the occurrence of signs and symptoms will be recorded. With this data, the reproducibility and efficacy of the protocol will be evaluated. The third stage of this project consists of a cross-sectional observational study, in which a new sample of participants will be evaluated by two independent physiotherapists for clinical and physical variables, and based on these data will be stratified by the new protocol by the same evaluators independently. After these procedures, the protocol´s agreement between evaluators will be analyzed.

Enrollment

120 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Main medical diagnostic of any cardiovascular disease and/or presence of cardiovascular risk factors
  • Be participating in exercise-based cardiac rehabilitation

Exclusion criteria

  • Orthopedic and/or neurologic conditions that preclude the realization of any of the physical and clinical evaluations
  • Do not complete 24 cardiac rehabilitation sessions during the follow-up period

Trial design

120 participants in 3 patient groups

Stage 1 - Development of the new cardiac risk stratification protocol
Description:
This will be a prospective cohort study, in which individuals attending cardiac rehabilitation programs will be assessed by clinical and physical variables that will be used to guide the elaboration of the cardiac risk stratification protocol. After this initial evaluation, the volunteers will be followed for 2 months during their habitual cardiac rehabilitation routine for the evaluation and registry of the occurrence of minor adverse events, defined as signs and symptoms (arrhythmias, blood pressure alterations, tachypnea, pallor, chest pain, cramps, muscle pain, fatigue, and nausea). The cardiac rehabilitation program in which the volunteers will be recruited is based on moderate-intensity aerobic exercise.
Treatment:
Other: Exercise-based cardiac rehabilitation program (Stage 1)
Stage 2 - Reproducibility and efficiency of the new protocol
Description:
This will be a prospective cohort study, in which a new sample of individuals attending cardiac rehabilitation programs will be assessed by clinical and physical variables and stratified in one of the three following risk classes: "low risk", "moderate risk", and "high risk" accordingly to the new risk stratification protocol. After that, the sample will be followed for 2 months of rehabilitation to the evaluation of the occurrence of signs and symptoms. The cardiac rehabilitation program from where the volunteers will be recruited is based on moderate-intensity aerobic exercise and resistance training. With these data, the reproducibility and efficiency of the protocol will be evaluated.
Treatment:
Other: Exercise-based cardiac rehabilitation program (Stage 2)
Stage 3 - Protocols´ agreement between evaluators
Description:
This will be a cross-sectional observational study in which a new sample of participants will be evaluated by two independent physiotherapists for clinical and physical variables, and based on these data will be stratified by the new protocol by the same evaluators independently. After these procedures, the protocol´s agreement between evaluators will be analyzed.

Trial contacts and locations

1

Loading...

Central trial contact

Luiz Carlos Marques Vanderlei, PhD; Maria Júlia Lopez Laurino, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems